Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255

Annals of Oncology

Volumn 11, Issue 9, 2000, Pages 1141-1146

  Lichtman, S M ^a   Niedzwiecki, D ^b   Barcos, M ^c   Carlisle, T L ^d   Cooper, M R ^e   Johnson, J L ^b   Peterson, B A ^f  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

CHOPE; Infusional therapy; Non Hodgkin's lymphoma; Refractory lymphoma; Relapsed lymphoma

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER REGRESSION; CANCER RESISTANCE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG INFUSION; FEMALE; HUMAN; LEUKOPENIA; MALE; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA;

EID: 0033788029     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008395400069     Document Type: Article

References (21)

1. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma
2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
3. COPBLAM III: Infusional combination chemotherapy for diffuse large-cell lymphoma
4. Infusional chemotherapy (EPOCH) in patients with refractory or relapsed lymphoma
5. Infusional chemotherapy for non-Hodgkin's lymphoma
6. CODBLAM IV chemotherapy for large cell lymphoma: Sequential use of infusional vincristine and bleomycin and 'high-dose' consolidation
7. Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: Evidence for a schedule-dependent effect favoring infusional administration of chemotherapy
8. Prolonged administration of low-dose, infusional etoposide in patients with etoposide-sensitive neoplasms: A phase I-II study
9. COP-BLAM multidrug infusion chemotherapies for lymphoma: Results in a community hospital setting
10. Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen
11. EPOCH chemotherapy: Toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma
12. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma
13. Dose-intensified cyclophosphamide (C) and etoposide (E) in CHOP plus E (CHOPE) therapy of diffuse lymphomas (IWF E-H), CALGB 8852
14. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage
15. High-dose CHOP induction therapy for poor prognosis aggressive NHL (CALGB 9351): FFP differs at high and low accrual institutions
16. Nonparametric estimation from incomplete observations
17. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose ara-C and dexamethasone (DHAP)
18. ESHAP - An effective chemotherapy regimen in refractory and relapsing lymphoma: A four-year follow-up study
19. Ifosfamide combinations in lymphoma
20. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma
21. A phase I trial of high-dose oral tamoxifen and CHOPE